Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Net Debt / EBITDA

Arbutus Biopharma Cp Net Debt / EBITDA Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Net Debt / EBITDA from 2019 to 2019. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
Other Ratios Metrics:
  • Arbutus Biopharma Cp Total Debt / Capital for the quarter ending December 12, 2017 was $6m a 3.27% increase of 0m year over year
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
  • Arbutus Biopharma Cp Total Debt / Equity for the quarter ending December 12, 2017 was $7m a 3.48% increase of 0m year over year
View Chart On Koyfin